Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Amlexanox As a Possible Breakthrough Drug for MLL/AF4 -Positive Acute Lymphoblastic Leukemia

Hayato Tamai, MD PhD, Hiroki Yamaguchi, MD PhD, Koichi Miyake, MD PhD, Miyuki Takatori, Tomoaki Kitano, Syunsuke Yui, MD, Keiko Fukunaga, MD, Kazutaka Nakayama, MD PhD, Koiti Inokuchi, PhD MD

Blood (2016) 128 (22): 1590.

https://doi.org/10.1182/blood.V128.22.1590.1590

Published: 2016

Journal Articles

The D816V C-Kit Mutation Confers Higher Proliferation Activity By JAK-STAT and Src Family Kinase Pathways Compared to N822K C-Kit Mutation in Core-Binding Factor Acute Myeloid Leukemia

Ikuko Omori, MD, Hiroki Yamaguchi, MD PhD, Tomoaki Kitano, Noriko Miyake, PhD, Koichi Miyake, MD PhD, Koiti Inokuchi, PhD MD

Blood (2014) 124 (21): 2224.

https://doi.org/10.1182/blood.V124.21.2224.2224

Published: 2014

Journal Articles

Bone Marrow Cell Based Enzyme Replacement Prolongs Survival and Improves Disease Phenotypes In a Mouse Model Of Lethal Hypophosphatasia

Osamu Iijima, PhD, Koichi Miyake, MD, PhD, Aki Nakamura, DDS, Tsutomu Igarashi, MD, PhD, Chizu Kanokoda, Atsushi Watanabe, MD, PhD, Takashi Shimada, MD, PhD

Blood (2013) 122 (21): 2897.

https://doi.org/10.1182/blood.V122.21.2897.2897

Published: 2013

Journal Articles

Rescue of Lethal Hypophosphatasia Mice by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow Cells.

Osamu Iijima, PhD, Koichi Miyake, MD, PhD, Hanako Sugano-Tajima, MD, PhD, Tsutomu Igarashi, MD, PhD, Chizu Kanokoda, Atsushi Watanabe, MD, PhD, Takashi Shimada, MD, PhD

Blood (2012) 120 (21): 3154.

https://doi.org/10.1182/blood.V120.21.3154.3154

Published: 2012

Journal Articles

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Hiroki Yamaguchi, MD, PhD, Masahiro Okabe, MD, Kazuo Dan, MD, PhD, Koiti Inokuchi, PhD, MD, Takashi Shimada, MD, PHD

Blood (2010) 116 (21): 2477.

https://doi.org/10.1182/blood.V116.21.2477.2477

Published: 2010

Journal Articles

A Single Intramuscular Injection of AAV-8 Vector Expressing MDA7/IL-24 Efficiently Suppresses Tumor Growth Mediated by Multiple Anti-Cancer Mechanisms In Lymphoma Model Mice.

Nanya Wang, MD, Bai Fan, MD, Noriko Miyake, PhD, Koichi Miyake, MD, PhD, Takashi Shimada, MD, PhD

Blood (2010) 116 (21): 1474.

https://doi.org/10.1182/blood.V116.21.1474.1474

Published: 2010

Journal Articles

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Miyuki Takatori, Noriko Miyake, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Takashi Shimada, MD, PHD, Koiti Inokuchi, PhD, MD

Blood (2010) 116 (21): 61.

https://doi.org/10.1182/blood.V116.21.61.61

Published: 2010

Journal Articles

Deficient Ribosomal Protein S19 in Diamond-Blackfan Anemia Causes a Reduction in bcl-2 and Bad and Leads to Apoptosis in Erythroid Progenitor Cells.

Koichi Miyake, MD, PhD, Taiju Utsugisawa, MD, PhD, Johan Flygare, Thomas Kiefer, MD, Isao Hamaguchi, MD, PhD, Johan Richter, MD, PhD, Stefan Karlsson, MD, PhD

Blood (2005) 106 (11): 131.

https://doi.org/10.1182/blood.V106.11.131.131

Published: 2005

Journal Articles

Apoptotic Change Is a Major Reason for Defect in Early Erythroid Development in Cell Line Models for Ribosomal Protein (RP) S19 Deficient Diamond-Blackfan Anemia.

Koichi Miyake, MD, PhD, Taiju Utsugisawa, MD, PhD, Johan Flygare, Thomas Kiefer, MD, Johan Richter, MD, PhD, Maciej Wiznerowicz, MD, PhD, Didier Trono, MD, PhD, Stefan Karlsson, MD, PhD

Blood (2004) 104 (11): 2840.

https://doi.org/10.1182/blood.V104.11.2840.2840

Published: 2004

NARROW

Amlexanox As a Possible Breakthrough Drug for MLL/AF4 -Positive Acute Lymphoblastic Leukemia

The D816V C-Kit Mutation Confers Higher Proliferation Activity By JAK-STAT and Src Family Kinase Pathways Compared to N822K C-Kit Mutation in Core-Binding Factor Acute Myeloid Leukemia

Bone Marrow Cell Based Enzyme Replacement Prolongs Survival and Improves Disease Phenotypes In a Mouse Model Of Lethal Hypophosphatasia

Rescue of Lethal Hypophosphatasia Mice by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow Cells.

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

A Single Intramuscular Injection of AAV-8 Vector Expressing MDA7/IL-24 Efficiently Suppresses Tumor Growth Mediated by Multiple Anti-Cancer Mechanisms In Lymphoma Model Mice.

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Deficient Ribosomal Protein S19 in Diamond-Blackfan Anemia Causes a Reduction in bcl-2 and Bad and Leads to Apoptosis in Erythroid Progenitor Cells.

Apoptotic Change Is a Major Reason for Defect in Early Erythroid Development in Cell Line Models for Ribosomal Protein (RP) S19 Deficient Diamond-Blackfan Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only